1. Home
  2. CIEN vs HALO Comparison

CIEN vs HALO Comparison

Compare CIEN & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ciena Corporation

CIEN

Ciena Corporation

HOLD

Current Price

$346.33

Market Cap

60.7B

Sector

Utilities

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$112.24

Market Cap

12.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CIEN
HALO
Founded
1992
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.7B
12.0B
IPO Year
1996
2001

Fundamental Metrics

Financial Performance
Metric
CIEN
HALO
Price
$346.33
$112.24
Analyst Decision
Strong Buy
Buy
Analyst Count
14
11
Target Price
$382.69
$78.64
AVG Volume (30 Days)
2.1M
1.3M
Earning Date
06-04-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
46.55
N/A
EPS
4.34
3.11
Revenue
$4,769,507,000.00
$151,862,000.00
Revenue This Year
$30.83
$28.24
Revenue Next Year
$19.87
$12.56
P/E Ratio
$79.38
$35.27
Revenue Growth
18.79
N/A
52 Week Low
$133.88
$61.23
52 Week High
$637.51
$111.15

Technical Indicators

Market Signals
Indicator
CIEN
HALO
Relative Strength Index (RSI) 44.13 70.03
Support Level $317.45 $103.47
Resistance Level $365.90 N/A
Average True Range (ATR) 20.30 2.75
MACD 1.05 -0.63
Stochastic Oscillator 43.80 98.74

Price Performance

Historical Comparison
CIEN
HALO

About CIEN Ciena Corporation

Ciena is a leader in high-speed optical connectivity, providing systems, components, and automation software for telecom providers and enterprises, such as data centers, to enable long-distance connectivity. The company operates through four primary business segments: networking platforms, platform software and services, Blue Planet automation software, and global services. While telecom carriers remain important customers, cloud providers and hyperscalers now drive a significant portion of the business. To meet the demands of AI data centers, customers are adopting Ciena's WaveLogic 6 platform, the first to support 1.6 terabits-per-second capacity.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: